Study reveals maternal and neonatal benefits of Pfizer COVID-19 mRNA vaccine
A new commentary, published as an ‘In-Press Preview’ in the Journal of Clinical Investigation, addresses the salient issue of vaccination against the coronavirus disease (COVID-19) in pregnancy and potential antibody transfer to the fetus – and provides the evidence in support of messenger RNA (mRNA) vaccine safety and efficacy for both maternal and child health.
Israel General Hebrew University Ofer Beharier Antigen Panel Hebrew University Medical Center In Press Preview
Source: news-medical.net